Fundamental dimension Equity attribute | ABCLLeader $11.82▲+3.96% Cap $3.83BP/E -21.9x QuantScore51/100 | ABSIPeer $9.18▼-2.03% Cap $1.58BP/E -11.5x QuantScore44/100 | DNAPeer $9.99▲+2.88% Cap $672.7MP/E -2.0x QuantScore30/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
58/100 |
54/100 |
71/100 |
Valuation Multiples, PEG & DCF upside | 0/100 | 0/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 75/100 | 67/100 | 39/100 |
Growth Revenue / earnings growth & margins | 47/100 | 20/100 | 38/100 |
Sentiment Analyst ratings, targets & revisions | 77/100 | 80/100 | 4/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -21.9x | -11.5x | -2.0x |
Forward P/E (next FY) | -17.8x | -11.5x | -2.6x |
EV / EBITDA (TTM) | -22.8x | -13.4x | -4.1x |
Price / Sales | 57.9x | 1009.2x | 6.0x |
Price / Free Cash Flow | -21.3x | -14.5x | -3.5x |
PEG ratio | 40.30 | -0.69 | -0.13 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | 4 / 9 | 2 / 9 |
Altman Z-Score | 5.35 (Safe) | 38.13 (Safe) | -8.73 (Distress) |
Total debt / equity | 0.15 | 0.01 | 0.96 |
Quick ratio | 12.6x | 10.6x | 4.6x |
Interest coverage | — | -2263.8x | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +160.6% | -38.2% | -25.1% |
Net income growth YoY | +10.1% | -11.7% | +42.8% |
Gross margin (TTM) | 75.0% | -255.9% | 80.1% |
Operating margin (FY) | -289.0% | -4454.2% | -185.3% |
FCF margin (FY) | -231.7% | -3358.3% | -105.0% |
5. Trailing price performancePrice change over period |
1M return | -6.6% | -11.3% | -2.5% |
3M return | +122.6% | +21.4% | +35.7% |
6M return | +184.8% | +133.0% | +26.9% |
Year to date | +245.6% | +163.0% | +20.2% |
1Y return | +108.8% | +115.0% | -26.4% |
3Y return | +165.6% | +652.5% | -84.1% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-1.45 -112.3% premium | $0.0418 -99.5% premium | $-30.33 -403.6% premium |
Wall Street consensus target | $15.40 +30.3% · range $7.00–$30.00 | $13.60 +48.1% · range $10.00–$16.00 | $5.00 -49.9% · range $5.00–$5.00 |
Consensus stance | 92% Buy8% Hold0% Sell | 85% Buy8% Hold8% Sell | 36% Buy27% Hold36% Sell |